Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo
- PMID: 19258344
- DOI: 10.1093/hmg/ddp101
Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is a late onset disorder characterized by progressive weakening of specific muscles. It is caused by short expansions of the N-terminal polyalanine tract in the poly(A) binding protein nuclear 1 (PABPN1), and it belongs to the group of protein aggregation diseases, such as Huntington's, Parkinson's and Alzheimer diseases. Mutant PABPN1 forms nuclear aggregates in diseased muscles in both patients and animal models. Intrabodies are antibodies that are modified to be expressed intracellularly and target specific antigens in subcellular locations. They are commonly generated by artificially linking the variable domains of antibody heavy and light chains. However, natural single-chain antibodies are produced in Camelids and, when engineered, combined the advantages of being single-chain, small sized and very stable. Here, we determine the in vivo efficiency of Llama intrabodies against PABPN1, using the established Drosophila model of OPMD. Among six anti-PABPN1 intrabodies expressed in muscle nuclei, we identify one as a strong suppressor of OPMD muscle degeneration in Drosophila, leading to nearly complete rescue. Expression of this intrabody affects PABPN1 aggregation and restores muscle gene expression. This approach promotes the identification of intrabodies with high therapeutic value and highlights the potential of natural single-chain intrabodies in treating protein aggregation diseases.
Similar articles
-
Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.Hum Mol Genet. 2006 Jan 1;15(1):105-11. doi: 10.1093/hmg/ddi432. Epub 2005 Nov 30. Hum Mol Genet. 2006. PMID: 16319127
-
Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.Int J Biochem Cell Biol. 2006;38(9):1457-62. doi: 10.1016/j.biocel.2006.01.016. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16530457 Review.
-
Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD.FEBS Lett. 2010 Apr 16;584(8):1558-64. doi: 10.1016/j.febslet.2010.03.010. Epub 2010 Mar 10. FEBS Lett. 2010. PMID: 20226184
-
Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.Traffic. 2005 Sep;6(9):766-79. doi: 10.1111/j.1600-0854.2005.00315.x. Traffic. 2005. PMID: 16101680
-
Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy.Hum Gene Ther. 2015 May;26(5):286-92. doi: 10.1089/hum.2015.014. Epub 2015 May 11. Hum Gene Ther. 2015. PMID: 25860803 Review.
Cited by
-
Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models.Neurobiol Dis. 2020 Apr;137:104770. doi: 10.1016/j.nbd.2020.104770. Epub 2020 Jan 23. Neurobiol Dis. 2020. PMID: 31982516 Free PMC article. Review.
-
Recent Progress in Oculopharyngeal Muscular Dystrophy.J Clin Med. 2021 Mar 29;10(7):1375. doi: 10.3390/jcm10071375. J Clin Med. 2021. PMID: 33805441 Free PMC article. Review.
-
Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.Cell Death Dis. 2013 Oct 3;4(10):e821. doi: 10.1038/cddis.2013.342. Cell Death Dis. 2013. PMID: 24091664 Free PMC article.
-
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.Med Microbiol Immunol. 2009 Aug;198(3):157-74. doi: 10.1007/s00430-009-0116-7. Epub 2009 Jun 16. Med Microbiol Immunol. 2009. PMID: 19529959 Free PMC article. Review.
-
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement.Mol Ther Nucleic Acids. 2019 Apr 15;15:12-25. doi: 10.1016/j.omtn.2019.02.003. Epub 2019 Feb 15. Mol Ther Nucleic Acids. 2019. PMID: 30831428 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
